Statistics for Avidity Biosciences (id:6466 RNA)

Valuation metrics

Market cap

5.58B

Enterprise value

3.99B

Trailing P/E (ttm)

-14.86

Forward P/E

-15.42

PEG ratio

-15.42

Price/Sales (ttm)

551.08

Price/Book (mrq)

3.70

Enterprise Value/Revenue

394.81

Enterprise Value/EBITDA

-12.40

Overview

Shares outstanding

119.31M

Float

98.96M

Shares short

14.88M

% Held by insiders

0.05%

% Held by institutions

0.98%

Average volume (10 days)

1.09M

Average volume (90 days)

Price summary

52-Week low

5.97

52-Week high

56.00

52-Week change

85.53%

Beta

0.91

50-Day moving average

44.71

200-Day moving average

33.67

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-4,200.94%

Operational effectiveness

Return on assets

-18.33%

Return on equity

-27.76%

Income statement

Revenue (ttm)

0.10

Revenue per share (ttm)

0.10

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-322,036,000.00

Net income to common (ttm)

-280,488,000.00

Diluted EPS (ttm)

-2.95

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.59B

Total cash per share (mrq)

13.32

Total debt (mrq)

7.60M

Total Debt/Equity (mrq)

0.51

Current ratio (mrq)

1.78K%

Book value per share (mrq)

12.64

Cash flow

Cash flow statement

-184,498,000.00

Levered free cash flow (LFCF)

-135,189,632.00